#Alzheimer's_Research
LightNews LightNews
newsen.bsky.social
Cure Alzheimer's Fund Achieves a Milestone with 1,000th Research Grant Award#United_States#Alzheimer's_Disease#Wellesley#Alzheimer's_Research#Cure_Alzheimer's_Fund
Cure Alzheimer's Fund Achieves a Milestone with 1,000th Research Grant Award
Cure Alzheimer’s Fund has awarded its 1,000th grant, marking a significant step in research to combat Alzheimer's disease and offer hope for future treatments.
third-news.com
October 7, 2025 at 9:14 AM
newsen.bsky.social
Cure Alzheimer's Fund Welcomes Stephanie Wasco as New Executive VP for Marketing and Communications#USA#Alzheimer's_Research#Wellesley_Hills#Cure_Alzheimer's_Fund#Stephanie_Wasco
Cure Alzheimer's Fund Welcomes Stephanie Wasco as New Executive VP for Marketing and Communications
Cure Alzheimer's Fund has appointed Stephanie Wasco as the new Executive Vice President of Marketing and Communications, enhancing its mission.
third-news.com
August 20, 2026 at 10:43 AM
newsen.bsky.social
Exploring Breakthroughs in Alzheimer's Research with Takashi Iwatubo#Japan#Tokyo#Alzheimer's_Research#DOCTOR'S_MAGAZINE#Takashi_Iwatubo
Exploring Breakthroughs in Alzheimer's Research with Takashi Iwatubo
This article delves into the groundbreaking work of Takashi Iwatubo, who has significantly advanced Alzheimer's disease research in Japan, paving the way for innovative treatments.
third-news.com
August 25, 2026 at 7:32 AM
newsen.bsky.social
Neuroscientist Dr. Bradley Hyman Joins Karen Toffler Charitable Trust's Advisory Board to Enhance Brain Health Research#USA#Los_Angeles#Alzheimer's_Research#Bradley_Hyman#Karen_Toffler_Trust
Neuroscientist Dr. Bradley Hyman Joins Karen Toffler Charitable Trust's Advisory Board to Enhance Brain Health Research
Dr. Bradley Hyman, a prominent Harvard neuroscientist, has been appointed to the Karen Toffler Charitable Trust's Advisory Board, aiming to boost brain health research and support young scientists.
third-news.com
August 18, 2026 at 12:18 PM
newsen.bsky.social
AD/PD™ 2027 Conference Calls for Research Abstracts on Neurodegenerative Diseases#Spain#Barcelona#Neurodegenerative_Diseases#Alzheimer's_Research#ADPD_Conference
AD/PD™ 2027 Conference Calls for Research Abstracts on Neurodegenerative Diseases
The AD/PD™ 2027 conference invites global researchers to submit abstracts on Alzheimer's and Parkinson's diseases by September 1, 2026, in Barcelona.
third-news.com
August 5, 2026 at 12:39 PM
newsen.bsky.social
Cumulus Neuroscience Unveils Groundbreaking Data on Alzheimer’s Trial Screening at AAIC 2026#USA#London#Cumulus_Neuroscience#NeuLogiq#Alzheimer's_Research
Cumulus Neuroscience Unveils Groundbreaking Data on Alzheimer’s Trial Screening at AAIC 2026
Cumulus Neuroscience showcased compelling data at AAIC 2026, revealing a two-minute digital task that meets clinical benchmarks for Alzheimer's trial participant selection.
third-news.com
July 15, 2026 at 2:33 PM
newsen.bsky.social
CenExel Welcomes Dr. Arun Singh to Lead Toms River Clinical Research Hub#United_States#Toms_River#Alzheimer's_Research#CenExel#Dr._Arun_Singh
CenExel Welcomes Dr. Arun Singh to Lead Toms River Clinical Research Hub
CenExel has appointed Dr. Arun Singh as the primary Principal Investigator for its Toms River clinical research site, enhancing its Alzheimer's research leadership.
third-news.com
April 29, 2026 at 3:08 PM
newsen.bsky.social
Leading the Charge in Alzheimer's Research: Isobel Coleman Appointed CEO of ADDF#United_States#New_York#Alzheimer's_Drug_Discovery_Foundation#Alzheimer's_Research#Isobel_Coleman
Leading the Charge in Alzheimer's Research: Isobel Coleman Appointed CEO of ADDF
Isobel Coleman has been appointed as the new CEO of the Alzheimer's Drug Discovery Foundation, set to lead transformative advancements in Alzheimer's research and drug development.
third-news.com
March 11, 2026 at 2:34 PM
newsen.bsky.social
Randall J. Bateman Honored with 2026 Melvin R. Goodes Prize for Alzheimer’s Research#USA#St._Louis#Goodes_Prize#Alzheimer's_Research#Randall_Bateman
Randall J. Bateman Honored with 2026 Melvin R. Goodes Prize for Alzheimer’s Research
The Alzheimer's Drug Discovery Foundation recognizes Dr. Randall J. Bateman for his innovative contributions to Alzheimer's research and diagnostics.
third-news.com
February 18, 2026 at 3:30 PM
newsen.bsky.social
A Transformative $5 Million Donation to Help Combat Alzheimer's Disease#United_States#San_Antonio#UT_Health#Alzheimer’s_Research#Biggs_Institute
A Transformative $5 Million Donation to Help Combat Alzheimer's Disease
UT Health San Antonio receives a $5 million donation from Bill and Rebecca Reed to enhance Alzheimer's research and care.
third-news.com
February 12, 2026 at 7:45 PM
newsen.bsky.social
Cure Alzheimer's Fund Launches Consortium for Advancing Brain Aging Research#United_States#Wellesley#Alzheimer's_Research#Cure_Alzheimer's#Brain_Aging
Cure Alzheimer's Fund Launches Consortium for Advancing Brain Aging Research
Cure Alzheimer's Fund has announced a new Brain Aging Consortium aimed at understanding the biological processes of aging and its link to Alzheimer's disease risk. This collaboration represents a significant step toward promoting healthy cognitive aging.
third-news.com
February 5, 2026 at 3:05 PM
newsen.bsky.social
Alamar Biosciences Unveils Advancements with NULISAqpcr AD 5-Plex Blood Test for Alzheimer’s Research#USA#Fremont#Alamar_Biosciences#NULISAqpcr#Alzheimer's_Research
Alamar Biosciences Unveils Advancements with NULISAqpcr AD 5-Plex Blood Test for Alzheimer’s Research
Alamar Biosciences introduces its groundbreaking NULISAqpcr AD 5-plex assay, enhancing the early detection of Alzheimer's disease through blood biomarker analysis.
third-news.com
January 13, 2026 at 9:12 AM
newsen.bsky.social
Novoron Bioscience Receives $2.5 Million Grant to Advance Alzheimer's Research#USA#San_Diego#NIH_Grant#Alzheimer's_Research#Novoron_Bioscience
Novoron Bioscience Receives $2.5 Million Grant to Advance Alzheimer's Research
Novoron Bioscience has secured a $2.5 million grant from the NIH to enhance Alzheimer's drug discovery through advanced human brain organoids, aiming for clinical success.
third-news.com
January 6, 2026 at 5:09 PM
newsen.bsky.social
Circular Genomics Expands Advisory Board with Leading Alzheimer's Researchers to Enhance Neurology Advances#USA#San_Diego#Circular_Genomics#Alzheimer's_Research#Neurology_Experts
Circular Genomics Expands Advisory Board with Leading Alzheimer's Researchers to Enhance Neurology Advances
Circular Genomics announces the appointment of distinguished experts Michael Weiner and Timothy Hohman to its Scientific Advisory Board. This move aims to enhance advancements in Alzheimer's disease diagnostics.
third-news.com
December 8, 2025 at 2:21 PM
newsen.bsky.social
Novo Nordisk Unveils Promising Insights from Semaglutide Trials for Alzheimer's Treatment Development#USA#San_Diego#Semaglutide#Novo_Nordisk#Alzheimer’s_Research
Novo Nordisk Unveils Promising Insights from Semaglutide Trials for Alzheimer's Treatment Development
Novo Nordisk shared new data from phase 3 trials of semaglutide, highlighting its potential in Alzheimer’s research and the importance of exploring non-amyloid pathways.
third-news.com
December 4, 2025 at 3:59 PM
newsen.bsky.social
Alzheimer's Drug Discovery Foundation Launches New Campaign Focused on Scientific Innovation#USA#Palm_Beach#Alzheimer's_Drug_Discovery_Foundation#Alzheimer's_Research#Milestones_in_Motion
Alzheimer's Drug Discovery Foundation Launches New Campaign Focused on Scientific Innovation
The Alzheimer's Drug Discovery Foundation introduces Milestones in Motion and the fifth symposium season, advancing Alzheimer's research and support.
third-news.com
November 19, 2025 at 4:10 PM
newsen.bsky.social
New Study Reveals Air Pollution as a Risk Factor for Alzheimer's Disease and Proposes Preventive Solutions#USA#Tucson#Alzheimer's_Disease#Alzheimer's_Research#Pollution_Effects
New Study Reveals Air Pollution as a Risk Factor for Alzheimer's Disease and Proposes Preventive Solutions
A groundbreaking study links air pollution with Alzheimer's, revealing its risk starting as early as childhood. A prevention plan is introduced based on lifestyle changes.
third-news.com
November 6, 2025 at 1:36 PM
newsen.bsky.social
Alamar Biosciences Unveils NULISAqpcr™ BD-pTau217: A Game Changer in Alzheimer's Research#Alamar_Biosciences#NULISAqpcr#Alzheimer's_Research
Alamar Biosciences Unveils NULISAqpcr™ BD-pTau217: A Game Changer in Alzheimer's Research
Alamar Biosciences has launched a groundbreaking test, NULISAqpcr™ BD-pTau217, which enables non-invasive detection of brain biomarkers for Alzheimer's disease research.
third-news.com
October 10, 2025 at 6:17 PM
newsen.bsky.social
Alamar Biosciences Unveils NULISAqpcr™ BD-pTau217: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection#USA#Fremont#Alamar_Biosciences#NULISAqpcr#Alzheimer’s_Research
Alamar Biosciences Unveils NULISAqpcr™ BD-pTau217: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection
Discover Alamar Biosciences' revolutionary NULISAqpcr™ BD-pTau217 test, enhancing non-invasive detection of Alzheimer's biomarkers and transforming research.
third-news.com
October 10, 2025 at 6:16 PM
newsen.bsky.social
Alamar Biosciences Launches Revolutionary Non-Invasive Assay for Alzheimer's Research#USA#Fremont#Alamar_Biosciences#NULISAqpcr#Alzheimer's_Research
Alamar Biosciences Launches Revolutionary Non-Invasive Assay for Alzheimer's Research
Alamar Biosciences has introduced the NULISAqpcr™ BD-pTau217 Assay, a groundbreaking tool for non-invasive detection of Alzheimer’s biomarkers via blood samples.
third-news.com
October 10, 2025 at 5:53 PM
newsen.bsky.social
Alamar Biosciences Unveils Groundbreaking NULISAqpcr™ BD-pTau217 Test for Alzheimer's Research#USA#Fremont#Alamar_Biosciences#Alzheimer's_Research#pTau217
Alamar Biosciences Unveils Groundbreaking NULISAqpcr™ BD-pTau217 Test for Alzheimer's Research
Alamar Biosciences introduces NULISAqpcr™ BD-pTau217, a novel blood test enabling early detection of Alzheimer's biomarkers, enhancing research accuracy and precision.
third-news.com
October 10, 2025 at 4:49 PM
newsen.bsky.social
Cure Alzheimer's Fund Welcomes Dr. Natasha Hussain as New Executive VP of Research Management#USA#Alzheimer's_Research#CureAlz_Fund#Dr._Natasha_Hussain#Wellesley_Hills
Cure Alzheimer's Fund Welcomes Dr. Natasha Hussain as New Executive VP of Research Management
Cure Alzheimer's Fund has appointed Dr. Natasha Hussain as Executive Vice President of Research Management to enhance its research efforts against Alzheimer's disease.
third-news.com
September 9, 2025 at 11:11 AM
newsen.bsky.social
CaringKind Welcomes Dr. Kendra Ray as Chief Research Officer for Alzheimer's Initiatives#United_States#New_York#CaringKind#Alzheimer's_Research#Dr._Kendra_Ray
CaringKind Welcomes Dr. Kendra Ray as Chief Research Officer for Alzheimer's Initiatives
CaringKind has appointed Dr. Kendra Ray as Chief Research Officer, strengthening commitment to dementia care through innovative research.
third-news.com
August 18, 2025 at 10:12 AM
newsen.bsky.social
Ten Researchers Recognized for Their Contributions at Alzheimer's Association International Conference 2025#Canada#Toronto#Alzheimer's_Association#Alzheimer's_Research#AAIC_2025
Ten Researchers Recognized for Their Contributions at Alzheimer's Association International Conference 2025
The Alzheimer's Association International Conference 2025 honored ten researchers for their significant achievements and innovations in the field of Alzheimer's and dementia science, marking a pivotal moment in research advancements.
third-news.com
July 27, 2025 at 3:11 PM
newsen.bsky.social
Remembering Leonard A. Lauder: A Visionary Leader in Alzheimer's Research#United_States#New_York#Leonard_Lauder#ADDF#Alzheimer's_Research
Remembering Leonard A. Lauder: A Visionary Leader in Alzheimer's Research
The Alzheimer's Drug Discovery Foundation mourns the loss of Leonard A. Lauder, a transformative figure in Alzheimer's research funding and innovation.
third-news.com
June 15, 2025 at 8:43 PM